FDA Approves Xeomin for Comprehensive Upper Facial Wrinkle Treatment
October 29, 2024 | ABCS
The world of aesthetic treatments has exciting news: Xeomin®, a popular neuromodulator, has just received FDA approval for expanded use. The FDA recently approved Xeomin for the treatment of two major types of upper facial lines: forehead lines and crow’s feet (canthal lines). In addition to its existing approval for… Read More »